Device
Bicarbonate
Bicarbonate is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
1
20%
Ph not_applicable
3
60%
Ph phase_2
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)
Trials by Status
not_yet_recruiting120%
completed240%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate
NCT06270134
unknownnot_applicable
The Effects of Ankaferd Blood Stopper
NCT05438771
completedphase_2
Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery
NCT00484354
completednot_applicable
Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum
NCT02621762
unknownphase_3
Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)
NCT01640119
Clinical Trials (5)
Showing 5 of 5 trials
NCT06270134Not Applicable
Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate
NCT05438771Not Applicable
The Effects of Ankaferd Blood Stopper
NCT00484354Phase 2
Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery
NCT02621762Not Applicable
Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum
NCT01640119Phase 3
Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5